Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

Tremfya heads for filing in psoriatic arthritis

Tremfya heads for filing in psoriatic arthritis Probably the most eyecatching results in PsA from EULAR in Madrid, however, was Lilly's Talz in a head-to-head trial where it beat Humira. ... Lilly's drug did show an inferior side-effect profile compared to Humira, however, with a higher rate of

F-star hires ex-BMS immuno-oncology leader

Dr Kayitalire has over 20 years’ experience in oncology and immuno-oncology (IO) including spells at Celgene and Eli Lilly as well as BMS.

AZ says Farxiga cuts kidney disease in type 2 diabetes

AZ says Farxiga cuts kidney disease in type 2 diabetes AZ’s biggest competitor is Eli Lilly and Boehringer Ingelheim’s market-leading Jardiance (empagliflozin), which brought in $658m and around $2bn respectively for the two partners in 2018.

Lilly claims cluster headache first for CGRP drug Emgality

Lilly claims cluster headache first for CGRP drug Emgality Competition fierce in new class. Eli Lilly has pushed its nose in front of its rivals in the CGRP inhibitor market with the first FDA approval of a drug in the ... Emgality’s approval is based on a trial that compared the drug to placebo in 106

Latecomer Lilly preps its IL-23 drug for Crohn’s disease

Latecomer Lilly preps its IL-23 drug for Crohn’s disease Crohn’s could be an important indication for Lilly, as mirikizumab is very much playing catch-up in the IL-23 inhibitor category when it comes to psoriasis. ... positive data for mirikizumab in patients with chronic, inflammatory gastrointestinal

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics